Literature DB >> 26429099

A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.

Caitlin J Rinz1, Vanda A Lennon2, Fiona James3, James B Thoreson2, Kate L Tsai1, Alison N Starr-Moss1, H Dale Humphries4, Ling T Guo4, Anthony C Palmer5, Leigh Anne Clark6, G Diane Shelton7.   

Abstract

Congenital myasthenic syndromes (CMSs) are a group of rare genetic disorders of the neuromuscular junction resulting in structural or functional causes of fatigable weakness that usually begins early in life. Mutations in pre-synaptic, synaptic and post-synaptic proteins have been demonstrated in human cases, with more than half involving aberrations in nicotinic acetylcholine receptor (AChR) subunits. CMS was first recognized in dogs in 1974 as an autosomal recessive trait in Jack Russell Terriers (JRTs). A deficiency of junctional AChRs was demonstrated. Here we characterize a CMS in 2 contemporary cases of JRT littermates with classic clinical and electromyographic findings, and immunochemical confirmation of an approximately 90% reduction in AChR protein content. Loci encoding the 5 AChR subunits were evaluated using microsatellite markers, and CHRNB1 and CHRNE were identified as candidate genes. Sequences of the splice sites and exons of both genes revealed a single base insertion in exon 7 of CHRNE that predicts a frameshift mutation and a premature stop codon. We further demonstrated this pathogenic mutation in CHRNE in archival tissues from unrelated JRTs studied 34 years ago.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Canine; Muscle nicotinic acetylcholine receptor; Myasthenia gravis; Neuromuscular junction

Mesh:

Substances:

Year:  2015        PMID: 26429099     DOI: 10.1016/j.nmd.2015.09.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Congenital Myasthenic Syndrome in a Mixed Breed Dog.

Authors:  Theresa J Blakey; Jennifer R Michaels; Ling T Guo; Amy J Hodshon; G Diane Shelton
Journal:  Front Vet Sci       Date:  2017-10-17

2.  Botulinum Toxin Injection-Site Selection for a Smooth Shoulder Line: An Anatomical Study.

Authors:  Je Hun Lee; Key Youn Lee; Ji Young Kim; Woo Hyeon Son; Ji Heun Jeong; Young Gil Jeong; Seongoh Kwon; Seung Ho Han
Journal:  Biomed Res Int       Date:  2017-01-26       Impact factor: 3.411

3.  CHRNE compound heterozygous mutations in congenital myasthenic syndrome: A case report.

Authors:  Kunfang Yang; Hongyi Cheng; Fang Yuan; Linyi Meng; Rongrong Yin; Yuanfeng Zhang; Simei Wang; Chunmei Wang; Yanfen Lu; Jiaming Xi; Qin Lu; Yucai Chen
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

4.  Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation.

Authors:  Kate L Tsai; Karen M Vernau; Kathryn Winger; Danielle M Zwueste; Beverly K Sturges; Marguerite Knipe; D Colette Williams; Kendall J Anderson; Jacquelyn M Evans; Ling T Guo; Leigh Anne Clark; G Diane Shelton
Journal:  J Vet Intern Med       Date:  2019-11-26       Impact factor: 3.333

5.  The Dog Model in the Spotlight: Legacy of a Trustful Cooperation.

Authors:  Inès Barthélémy; Christophe Hitte; Laurent Tiret
Journal:  J Neuromuscul Dis       Date:  2019

Review 6.  Classification of myasthenia gravis and congenital myasthenic syndromes in dogs and cats.

Authors:  Thomas Mignan; Mike Targett; Mark Lowrie
Journal:  J Vet Intern Med       Date:  2020-07-15       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.